Plain-English translation of NCT04045470 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing a new microdevice—a tiny implant no bigger than a grain of rice—that can be placed directly into your skin cancer lesions. The device contains 19 different FDA-approved cancer drugs at very low doses, designed to see which drugs your cancer responds to best. Think of it as a personalized "test" happening right in your tumor to guide your future treatment.
Right now, doctors have to guess which cancer drug will work best for each patient, often through trial and error. This device was created to answer that question faster and more accurately by testing multiple drugs directly in your tumor tissue, so your doctor can choose the treatment most likely to help you.
You likely qualify if…
You likely don't qualify if…
You will have four tiny devices placed into two of your skin lesions during an outpatient procedure—this is similar to a skin biopsy. The devices stay in place for about 24 hours, after which your doctor removes them and takes a small sample of treated tumor tissue for analysis. If you're in the expansion part of the study, you'll also start standard cancer treatment as planned, and your doctor will monitor how your skin lesions respond over time.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
United States